First-Line Monotherapy With Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in Advanced Non-Small Cell Lung Cancer (NSCLC): Safety, Efficacy, and Correlation of Outcomes With PD-L1 Status Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Rizvi, NA
  • Shepherd, FA
  • Antonia, SJ
  • Brahmer, JR
  • Chow, LQ
  • Goldman, J
  • Juergens, Rosalyn
  • Borghaei, H
  • Ready, NE
  • Gerber, DE
  • Shen, Y
  • Harbison, C
  • Chen, AC
  • Gettinger, S

publication date

  • November 2014